Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA doesn't just approve generic drugs - it keeps watching them after they hit the market. Learn how FAERS, Sentinel, and MedWatch help catch safety issues, why complex generics need extra scrutiny, and what you can do if something feels off.
Read More